Category Archives: Brain Injury Treatment

NOKOMIS, Fla.--(BUSINESS WIRE)-- Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), announced today that its latest joint venture target, Amarantus BioSciences, Inc. (AMBS), expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI). The study, commissioned late last year, is a collaboration between Amarantus and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI. The effects of TBI can be debilitating to athletes, combat veterans and others at risk of repetitive or serious head trauma. The recent death of NFL great Junior Seau, widely believed to be related to TBI, has focused a great deal of attention on the need for an effective treatment. RBCC believes that Amarantus is close to developing that cure. The company expects the test results, scheduled to be announced next week, to show that Amarantus new protein therapy, MANF, effectively reduces cell death associated with TBI. RBCC and Amarantus are currently wrapping up due diligence toward a potential joint venture agreement to develop and market MANF as a treatment for disorders associated with endoplasmic reticulum stress, including traumatic brain injury, Parkinsons disease, Alzheimers disease … Continue reading →

28-05-2012 22:27 Uploaded to YouTube with the express permission of FOX Q13 News on Memorial Day 2012: Research institute hopes to offer hyperbaric oxygen treatment for vets with PTSD Sgt. Jeff Brennan returned from the Gulf War in 1992, and since then has been battling daily symptoms resulting from a traumatic brain injury and Post-Traumatic Stress Disorder. Read the rest of the story here: Excerpt from: Q13 FOX Research institute hopes to offer hyperbaric oxygen treatment for vets: Jeff Brennan - Video … Continue reading →

NOKOMIS, Fla.--(BUSINESS WIRE)-- Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC.OB), continues due diligence toward an agreement to help develop a promising new treatment for Traumatic Brain Injury (TBI), concern continues to grow over the troubling incidence of TBI among athletes and soldiers. The recent, tragic death of NFL great Junior Seau has led to intense speculation that the linebacker suffered from TBI inflicted on the gridiron. Even more disheartening is the number of American war veterans complaining of symptoms as they return from Afghanistan. In recent years, more than 200,000 troops have tested positive for traumatic brain injuries, including concussions. Currently, TBI and other neuropathic maladies can only be diagnosed after death, leaving many soldiers and athletes to wonder if they have it or not. RBCC hopes to help change that. The company is currently negotiating a potential joint venture with Amarantus BioSciences (AMBS.OB). AMBS is a biotech firm that has developed a therapeutic protein known as MANF to treat disorders associated with endoplasmic reticulum stress, including traumatic brain injury. If a definitive agreement is reached, RBCC will help AMBS secure funding to continue their research and development process on a mission to bring a potent new … Continue reading →

Public release date: 29-May-2012 [ | E-mail | Share ] Contact: George Hunka ghunka@aftau.org 212-742-9070 American Friends of Tel Aviv University Although the death toll is relatively low for people who suffer from traumatic brain injury (TBI), it can have severe, life-long consequences for brain function. TBI can impair a patient's mental abilities, impact memory and behavior, and lead to dramatic personality changes. And long-term medical treatment carries a high economic cost. Now, in research commissioned by the United States Air Force, Prof. Chaim Pick of Tel Aviv University's Sackler Faculty of Medicine and Dr. Nigel Greig of the National Institute of Aging in the US have discovered that Exendin-4, an FDA-approved diabetes drug, significantly minimizes damage in TBI animal models when administered shortly after the initial incident. Originally designed to control sugar levels in the body, the drug has recently been found effective in protecting neurons in disorders such as Alzheimer's disease. Prof. Pick's collaborators include his TAU colleagues Dr. Vardit Rubovitch, Lital Rachmany-Raber, and Prof. Shaul Schreiber, and Dr. David Tweedie of the National Institute of Aging in the US. Detailed in the journal Experimental Neurology, this breakthrough is the first step towards developing a cocktail of medications … Continue reading →

28-05-2012 12:48 US Marine Jeff Brennan talks about his career and life after serving several tours in the Middle East. Jeff looks forward to hyperbaric oxygen therapy (HBOT) at Restorix to treat his brain injuries from his time in the military serving his country. We hope everyone will donate to make his treatment happen! To donate, please go to Fundly: To learn more about The Restorix Foundation and hyperbarics, go to: Read more: Operation: Head Home - Jeff Brennan USMC - Video … Continue reading →

ISSAQUAH, Wash. Marine Sgt. Jeff Brennan returned from the Gulf War in 1992, and since then has been battling daily symptoms resulting from a traumatic brain injury andpost-traumatic stress disorder, or PTSD. While in combat, and on the training field, Brennan suffered several head injuries. The worst came from a 75-foot fall off a repel tower. When I hit the ground they said I bounced three times and completely blacked out," Brennan said. "I had a fracture in my face. I have a portion of my brain that has been diagnosed as dead. There is no activity whatsoever. The Marine Corps vet now has to use Post-It notes to remember simple daily tasks, and plans his day around when he takes his pain medication. After years of counseling and anti-depressants, Brennan is beginning a new form of treatment in a hyperbaric oxygen chamber at Restorix Research Institute in Issaquah. Patients go into the chamber for 60 minutes. Inside, they breathe 100 percent oxygen. The treatments are given five days a week for one to four months, depending on the severity of the symptoms. The treatment helps to repair damaged parts of the brain, said Dr. Latisha Smith. What we try … Continue reading →

27-05-2012 12:46 How Compensated Auto Accident Injury Claim, Dr. Chris McNeil, Chiropractor in Ferndale Michigan. Phone (248) 291-6873 Auto Accident Injury Payment, Ferndale Chiropractors 1200 W. 9 Mile Road Ferndale, MI 48220 Auto Accident Injury Compensation: Chiropractors 48220 Metro Detroit Chiropractors See more here: Brain Damage Auto Injury Claim Ferndale MI - Video … Continue reading →

27-05-2012 12:48 How Compensated Auto Accident Injury Claim, Dr. Chris McNeil, Chiropractor in Ferndale Michigan. Phone (248) 291-6873 Auto Accident Injury Payment, Ferndale Chiropractors 1200 W. 9 Mile Road Ferndale, MI 48220 Auto Accident Injury Compensation: Chiropractors 48220 Metro Detroit Chiropractors View original post here: How Compensated Auto Injury Brain Damage Ferndale MI - Video … Continue reading →

27-05-2012 13:09 How Compensated Car Accident Injury Claim, Dr. Chris McNeil, Chiropractor in Ferndale Michigan. Phone (248) 291-6873 Car Accident Injury Payment, Ferndale Chiropractors 1200 W. 9 Mile Road Ferndale, MI 48220 Car Accident Injury Compensation: Chiropractors 48220 Metro Detroit Chiropractors Originally posted here: Brain Damage Car Injury Claim Ferndale MI - Video … Continue reading →

27-05-2012 13:11 How Compensated Car Accident Injury Claim, Dr. Chris McNeil, Chiropractor in Ferndale Michigan. Phone (248) 291-6873 Car Accident Injury Payment, Ferndale Chiropractors 1200 W. 9 Mile Road Ferndale, MI 48220 Car Accident Injury Compensation: Chiropractors 48220 Metro Detroit Chiropractors Read the original: How Compensated Car Injury Brain Damage Ferndale MI - Video … Continue reading →